Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Application of Synthetic Tumor-Specific Promoters Responsive to the Tumor Microenvironment.

Cafferata EG, Lopez MV, Nuñez FJ, Maenza MAR, Podhajcer OL.

Methods Mol Biol. 2017;1651:213-227. doi: 10.1007/978-1-4939-7223-4_16.

PMID:
28801910
2.

Synthetic Tumor-Specific Promoters for Transcriptional Regulation of Viral Replication.

Lopez MV, Cafferata EG, Viale DL, Podhajcer OL.

Methods Mol Biol. 2017;1651:113-130. doi: 10.1007/978-1-4939-7223-4_9.

PMID:
28801903
3.

Personalized virotherapy in cancer.

Cafferata EG, Podhajcer OL.

Aging (Albany NY). 2015 May;7(5):288-9. No abstract available.

4.

A Novel CDC25B Promoter-Based Oncolytic Adenovirus Inhibited Growth of Orthotopic Human Pancreatic Tumors in Different Preclinical Models.

Weber HL, Gidekel M, Werbajh S, Salvatierra E, Rotondaro C, Sganga L, Haab GA, Curiel DT, Cafferata EG, Podhajcer OL.

Clin Cancer Res. 2015 Apr 1;21(7):1665-74. doi: 10.1158/1078-0432.CCR-14-2316. Epub 2015 Jan 8.

5.

Enhanced CRAd activity using enhancer motifs driven by a nucleosome positioning sequence.

Bravo S, Núñez F, Cruzat F, Cafferata EG, De Ferrari GV, Montecino M, Podhajcer OL.

Mol Ther. 2013 Jul;21(7):1403-12. doi: 10.1038/mt.2013.93. Epub 2013 May 28.

6.

Therapeutic improvement of a stroma-targeted CRAd by incorporating motives responsive to the melanoma microenvironment.

Viale DL, Cafferata EG, Gould D, Rotondaro C, Chernajovsky Y, Curiel DT, Podhajcer OL, Veronica Lopez M.

J Invest Dermatol. 2013 Nov;133(11):2576-2584. doi: 10.1038/jid.2013.191. Epub 2013 Apr 19.

7.

Carnosic acid inhibits the proliferation and migration capacity of human colorectal cancer cells.

Barni MV, Carlini MJ, Cafferata EG, Puricelli L, Moreno S.

Oncol Rep. 2012 Apr;27(4):1041-8. doi: 10.3892/or.2012.1630. Epub 2012 Jan 11.

8.

Pleiotrophin over-expression provides trophic support to dopaminergic neurons in parkinsonian rats.

Taravini IR, Chertoff M, Cafferata EG, Courty J, Murer MG, Pitossi FJ, Gershanik OS.

Mol Neurodegener. 2011 Jun 7;6:40. doi: 10.1186/1750-1326-6-40.

9.

Tumor associated stromal cells play a critical role on the outcome of the oncolytic efficacy of conditionally replicative adenoviruses.

Lopez MV, Viale DL, Cafferata EG, Bravo AI, Carbone C, Gould D, Chernajovsky Y, Podhajcer OL.

PLoS One. 2009;4(4):e5119. doi: 10.1371/journal.pone.0005119. Epub 2008 Apr 8.

10.

A novel A33 promoter-based conditionally replicative adenovirus suppresses tumor growth and eradicates hepatic metastases in human colon cancer models.

Cafferata EG, Macció DR, Lopez MV, Viale DL, Carbone C, Mazzolini G, Podhajcer OL.

Clin Cancer Res. 2009 May 1;15(9):3037-49. doi: 10.1158/1078-0432.CCR-08-1161. Epub 2009 Mar 31.

11.

Expression of a suicidal gene under control of the human secreted protein acidic and rich in cysteine (SPARC) promoter in tumor or stromal cells led to the inhibition of tumor cell growth.

Lopez MV, Blanco P, Viale DL, Cafferata EG, Carbone C, Gould D, Chernajovsky Y, Podhajcer OL.

Mol Cancer Ther. 2006 Oct;5(10):2503-11.

12.

TNF-alpha enhances estrogen-induced cell proliferation of estrogen-dependent breast tumor cells through a complex containing nuclear factor-kappa B.

Rubio MF, Werbajh S, Cafferata EG, Quaglino A, Coló GP, Nojek IM, Kordon EC, Nahmod VE, Costas MA.

Oncogene. 2006 Mar 2;25(9):1367-77.

PMID:
16331275
13.

Tyrosine kinase c-Src constitutes a bridge between cystic fibrosis transmembrane regulator channel failure and MUC1 overexpression in cystic fibrosis.

González-Guerrico AM, Cafferata EG, Radrizzani M, Marcucci F, Gruenert D, Pivetta OH, Favaloro RR, Laguens R, Perrone SV, Gallo GC, Santa-Coloma TA.

J Biol Chem. 2002 May 10;277(19):17239-47. Epub 2002 Feb 28.

14.

Differential expression of CPD1 during postnatal development in the mouse cerebellum.

Radrizzani M, Vilá-Ortiz G, Cafferata EG, Di Tella MC, González-Guerrico A, Perandones C, Pivetta OH, Carminatti H, Idoyaga Vargas VP, Santa-Coloma TA.

Brain Res. 2001 Jul 13;907(1-2):162-74.

PMID:
11430900
15.

NF-kappaB activation is involved in regulation of cystic fibrosis transmembrane conductance regulator (CFTR) by interleukin-1beta.

Cafferata EG, Guerrico AM, Pivetta OH, Santa-Coloma TA.

J Biol Chem. 2001 May 4;276(18):15441-4. Epub 2001 Feb 5.

16.

Development of monoclonal oligobodies and chemically synthesized oligobodies.

Radrizzani M, Brocardo MG, Gonzalez Solveyra C, Bianchini M, Reyes GB, Cafferata EG, Vilá Ortiz G, Santa-Coloma TA.

Medicina (B Aires). 2000;60 Suppl 2:55-60.

PMID:
11188933
17.

Oligobodies: bench made synthetic antibodies.

Radrizzani M, Broccardo M, González Solveyra C, Bianchini M, Reyes GB, Cafferata EG, Santa-Coloma TA.

Medicina (B Aires). 1999;59(6):753-8.

PMID:
10752221
18.

Interleukin-1beta regulates CFTR expression in human intestinal T84 cells.

Cafferata EG, González-Guerrico AM, Giordano L, Pivetta OH, Santa-Coloma TA.

Biochim Biophys Acta. 2000 Feb 21;1500(2):241-8.

19.

TGF-beta1 up-regulates the mRNA for the Na+/Ca2+ exchanger in neonatal rat cardiac myocytes.

Carrillo C, Cafferata EG, Genovese J, O'Reilly M, Roberts AB, Santa-Coloma TA.

Cell Mol Biol (Noisy-le-grand). 1998 May;44(3):543-51.

PMID:
9620452
20.

Identification by differential display of a mRNA specifically induced by 12-O-tetradecanoylphorbol-13-acetate (TPA) in T84 human colon carcinoma cells.

Cafferata EG, Gonzalez-Guerrico AM, Pivetta OH, Santa-Coloma TA.

Cell Mol Biol (Noisy-le-grand). 1996 Jul;42(5):797-804.

PMID:
8832110
21.
23.

Supplemental Content

Loading ...
Support Center